Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.

In a large case-control study on breast cancer risk and serum hormone concentrations, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we examined to what extent the relationship of excess body weight with breast cancer risk may be explained by changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, S, Key, T, Peeters, P, Lahmann, P, Lukanova, A, Dossus, L, Biessy, C, Vineis, P, Sacerdote, C, Berrino, F, Panico, S, Tumino, R, Palli, D, Nagel, G, Linseisen, J, Boeing, H, Roddam, A, Bingham, S, Khaw, K, Chloptios, J, Trichopoulou, A, Trichopoulos, D, Tehard, B, Clavel-Chapelon, F, Gonzalez, C
Formato: Journal article
Lenguaje:English
Publicado: 2006
_version_ 1826293666628501504
author Rinaldi, S
Key, T
Peeters, P
Lahmann, P
Lukanova, A
Dossus, L
Biessy, C
Vineis, P
Sacerdote, C
Berrino, F
Panico, S
Tumino, R
Palli, D
Nagel, G
Linseisen, J
Boeing, H
Roddam, A
Bingham, S
Khaw, K
Chloptios, J
Trichopoulou, A
Trichopoulos, D
Tehard, B
Clavel-Chapelon, F
Gonzalez, C
author_facet Rinaldi, S
Key, T
Peeters, P
Lahmann, P
Lukanova, A
Dossus, L
Biessy, C
Vineis, P
Sacerdote, C
Berrino, F
Panico, S
Tumino, R
Palli, D
Nagel, G
Linseisen, J
Boeing, H
Roddam, A
Bingham, S
Khaw, K
Chloptios, J
Trichopoulou, A
Trichopoulos, D
Tehard, B
Clavel-Chapelon, F
Gonzalez, C
author_sort Rinaldi, S
collection OXFORD
description In a large case-control study on breast cancer risk and serum hormone concentrations, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we examined to what extent the relationship of excess body weight with breast cancer risk may be explained by changes in sex steroids. Height, weight, waist and hip circumferences, and serum measurements of testosterone [T], androstenedione [Delta4], dehydroepiandrosterone sulphate [DHEAS], estradiol [E2], estrone [E1] and sex-hormone binding globulin [SHBG] were available for 613 breast cancer cases, and 1,139 matched controls, who were all menopausal at the time of blood donation. Free T [fT] and free E2 [fE2] were calculated using mass action equations. Breast cancer risk was related to body mass index (BMI) (RR = 1.11 [0.99-1.25], per 5 kg/m2 increase in BMI), and waist (RR = 1.12 [1.02-1.24], per 10 cm increase) and hip circumferences (RR = 1.14 [1.02-1.27], per 10 cm increase). The increase in breast cancer risk associated with adiposity was substantially reduced after adjustment for any estrogens, especially for fE2 (from 1.11 [0.99-1.25] to 0.99 [0.87-1.12], from 1.12 [1.02-1.24] to 1.02 [0.92-1.14] and from 1.14 [1.02-1.27] to 1.05 [0.93-1.18] for BMI, waist and hip circumferences, respectively). A modest attenuation in excess risk was observed after adjustment for fT, but the remaining androgens had little effect on the association of body adiposity with breast cancer. Our data indicate that the relationship of adiposity with breast cancer in postmenopausal women could be partially explained by the increases in endogenous estrogens, and by a decrease in levels of SHBG.
first_indexed 2024-03-07T03:33:40Z
format Journal article
id oxford-uuid:bb8fbfcd-c47e-4ef9-b9ff-b0217affb4ea
institution University of Oxford
language English
last_indexed 2024-03-07T03:33:40Z
publishDate 2006
record_format dspace
spelling oxford-uuid:bb8fbfcd-c47e-4ef9-b9ff-b0217affb4ea2022-03-27T05:17:59ZAnthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bb8fbfcd-c47e-4ef9-b9ff-b0217affb4eaEnglishSymplectic Elements at Oxford2006Rinaldi, SKey, TPeeters, PLahmann, PLukanova, ADossus, LBiessy, CVineis, PSacerdote, CBerrino, FPanico, STumino, RPalli, DNagel, GLinseisen, JBoeing, HRoddam, ABingham, SKhaw, KChloptios, JTrichopoulou, ATrichopoulos, DTehard, BClavel-Chapelon, FGonzalez, CIn a large case-control study on breast cancer risk and serum hormone concentrations, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we examined to what extent the relationship of excess body weight with breast cancer risk may be explained by changes in sex steroids. Height, weight, waist and hip circumferences, and serum measurements of testosterone [T], androstenedione [Delta4], dehydroepiandrosterone sulphate [DHEAS], estradiol [E2], estrone [E1] and sex-hormone binding globulin [SHBG] were available for 613 breast cancer cases, and 1,139 matched controls, who were all menopausal at the time of blood donation. Free T [fT] and free E2 [fE2] were calculated using mass action equations. Breast cancer risk was related to body mass index (BMI) (RR = 1.11 [0.99-1.25], per 5 kg/m2 increase in BMI), and waist (RR = 1.12 [1.02-1.24], per 10 cm increase) and hip circumferences (RR = 1.14 [1.02-1.27], per 10 cm increase). The increase in breast cancer risk associated with adiposity was substantially reduced after adjustment for any estrogens, especially for fE2 (from 1.11 [0.99-1.25] to 0.99 [0.87-1.12], from 1.12 [1.02-1.24] to 1.02 [0.92-1.14] and from 1.14 [1.02-1.27] to 1.05 [0.93-1.18] for BMI, waist and hip circumferences, respectively). A modest attenuation in excess risk was observed after adjustment for fT, but the remaining androgens had little effect on the association of body adiposity with breast cancer. Our data indicate that the relationship of adiposity with breast cancer in postmenopausal women could be partially explained by the increases in endogenous estrogens, and by a decrease in levels of SHBG.
spellingShingle Rinaldi, S
Key, T
Peeters, P
Lahmann, P
Lukanova, A
Dossus, L
Biessy, C
Vineis, P
Sacerdote, C
Berrino, F
Panico, S
Tumino, R
Palli, D
Nagel, G
Linseisen, J
Boeing, H
Roddam, A
Bingham, S
Khaw, K
Chloptios, J
Trichopoulou, A
Trichopoulos, D
Tehard, B
Clavel-Chapelon, F
Gonzalez, C
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title_full Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title_fullStr Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title_full_unstemmed Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title_short Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
title_sort anthropometric measures endogenous sex steroids and breast cancer risk in postmenopausal women a study within the epic cohort
work_keys_str_mv AT rinaldis anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT keyt anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT peetersp anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT lahmannp anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT lukanovaa anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT dossusl anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT biessyc anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT vineisp anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT sacerdotec anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT berrinof anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT panicos anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT tuminor anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT pallid anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT nagelg anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT linseisenj anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT boeingh anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT roddama anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT binghams anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT khawk anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT chloptiosj anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT trichopouloua anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT trichopoulosd anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT tehardb anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT clavelchapelonf anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort
AT gonzalezc anthropometricmeasuresendogenoussexsteroidsandbreastcancerriskinpostmenopausalwomenastudywithintheepiccohort